ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
92 Medicines And Vaccines Now In Development For HIV/AIDS
America's pharmaceutical
research companies are testing 92 medicines and vaccines to treat or
prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).
December 1 marks the 20th anniversary of "World AIDS Day" -- a global
awareness campaign that originated at the 1988 World Summit of Ministers of
Health on Programmes for AIDS Prevention.
"We are greatly encouraged by the new, critically-important medicines
and vaccines in development to treat and prevent HIV infection," says PhRMA
President and CEO Billy Tauzin. "Pharmaceutical researchers are continuing
their efforts to develop new therapies and vaccines to improve and lengthen
the lives of HIV-infected patients."
The report found that of the 92 products in development, researchers
are studying 20 vaccines and 46 antivirals. These drugs are either in human
clinical trials or await approval by the U.S. Food and Drug Administration.
The report also lists 30 medicines to treat HIV/AIDS that have been
approved since the virus that causes AIDS was first identified more than 20
years ago. The first such medicine was developed in 1987, just four years
after the HIV virus was identified. The increased availability and
utilization of newer prescription medicines has helped to reduce the U.S.
death rate from AIDS substantially in recent years, according to government
statistics.
Despite that progress, AIDS remains a devastating and growing worldwide
health problem in developing countries, particularly in sub-Saharan Africa,
China, India and the Russian Federation. According to the Joint United
Nations Programme on HIV/AIDS, an estimated 32.7 million people worldwide
lived with HIV at the end of 2006.
This year, that figure grew to an estimated 33.2 million people living
with HIV, with an estimated 2.1 million people newly infected in 2007.
From 2000 to 2006, America's pharmaceutical research companies
contributed more than $6.7 billion to improve health care in the developing
world, according to the International Federation of Pharmaceutical
Manufacturers & Associations. The projects they underwrote included
building clinics to treat patients with HIV/AIDS, education and prevention
programs, initiatives to prevent mother-to-child transmission of HIV, and
donations of medicines for AIDS and related diseases. Companies also
provide AIDS drugs at significantly reduced prices in many countries.
"With HIV/AIDS medicines, a disease that was once a virtual death
sentence can now be controlled and treated as if it were a chronic
disease," adds Tauzin. "And the new medicines our scientists are working on
right now bring hope for even more promising results in the future."
To read the report on the PhRMA Web site, click on the following link:
http://www.phrma.org
The Pharmaceutical Research and Manufacturers of America (PhRMA)
represents the country's leading pharmaceutical research and biotechnology
companies, which are devoted to inventing medicines that allow patients to
live longer, healthier, and more productive lives. PhRMA companies are
leading the way in the search for new cures. PhRMA members alone invested
an estimated $43 billion in 2006 in discovering and developing new
medicines. Industry wide research and investment reached a record $55.2
billion in 2006.
Pharmaceutical Research and Manufacturers of America
http://innovation.org
92 Medicamente ºi vaccinuri în prezent în dezvoltare pentru HIV / SIDA - 92 Medicines And Vaccines Now In Development For HIV/AIDS - articole medicale engleza - startsanatate